Antibe Therapeutics Inc(Pre-Merger) ATBPF

IR responce

[yessim]

Im a little confused and may be wrong but with china running phase 3 themselves.....knowing
full well they could probably complete quicker than FDA........would this not directly confict
 with milestone payments.

[Goaweigh]

Can you elaborate ?

[yessim]

Look i have limited knowledge on such things, but if china approves .....why would they give 100 mil. in milstone payments. If someone can explain why Im wrong please tell me. my first buy in was X-mas 2017 and averaged up right up to last summer.....selling none along the way. Not trying to sound negative just seemed like a valid thought. Thx.

[Layth1990]

i think, first they paid 100m to obtain the license in china. the double digit royalties from revenues will benefit antibe later on. This will give you an idea on  how strong is the proof of concept. i think nuance will wait for phase 3 results in us. it will file it in china after, this way it will reduce the costs of clinical trials. nuance will be responsible for manifacturing and

[Actuarial]

Layth1990, I don't think Nuance will wait for phase 3 results in US as it will take much longer than if they do it themselves in China. While Nuance wait for ATE phase 3 results in US could have save some money, Nuance would also loss sales as any patent has an expiry date. Nuance has a lot of cash to burn and taking phase 3 in China is extremely cheap. In Canada, we pay people who participate

[3burtc]

Ya right, they'll pay 20 million upfront and wait for us lol. The standard royalty for a phase 3 drug is 15 %, chances are we are higher than that because of being a blockbuster. The royalty payments should be at least $300 million/year based on 20% market share. We should be at 50% because otenaproxesul fills an unmet need. GLTA .

[crow27]

Right off the bat Nuance gave ATB 20 million because they want this license. Nuance now has to do all the heavy lifting to run trials/get approval/distribute the product and sell the product. ATB will get the other 80 million in stages once Nuance moves this through the system or through certain stages. ATB is actually doing nothing for this 80 million. They get this money when Nuance reaches

[crow27]

Now do a few more deals like this or on better terms and ................. shareholders of this SMALL low share company are going to make a fortune. It happens this way all the time with BIO's. The payday is fast and huge.

[MrMugsy]

Sorry Yessim.  What is your question? MIlestone payments reduce the risk to the partner while providing cash to us as risk is reduced. Hope that helps.

[yessim]

K....Thx. guys Im just thinking wrong....all is good

[crow27]

The real question is how long will it take Nuance to bring this to market? All I know is that when Covid hit China they built a hospital in 6 days. They can move this very fast in my eyes and I think it is because of the huge gains on all fronts, not only the money.

[Actuarial]

Exactly. Also, CFDA is ease and fast with drug approvals. CFDA approved GV-971 (a new drug to treat Alz) though its data really sketchy. I expect to see OtenA get commercialized in 2022 in China.

[NotBornLastNite]

yessim, I appreciate your question, and the replys.  This, in part is why we are here, to learn and share information.  

[Goaweigh]

The liscence only kicks in when the final payment is made. No payment / no drug. Payments are usually triggered by milestones reached and China has it's own set of hudles that need to be cleared before a drug is approved. When we clear one hurdle we receieve another milestone payment, clear another hurdle and we receive another payment and then on final approval yet another payment, usually a